Pharma: UE has exclusive competence over patentability
With its judgment rendered on 18 July 2013 (Case C-414/11), the European Court of Justice (ECJ) held that the TRIPs (Trade-Related Aspects of Intellectual Property Rights) agreement falls within the field of the ‘common commercial policy of the union’.
The ECJ is consequently the court to which the interpretation of the TRIPs agreement is demanded, also with respect to patent law provisions, notwithstanding the level of harmonisation eventually reached among the member states…
If you are registered and logged in to the site, click on the link below to read the rest of the NCTM briefing. If not, please register or sign in with your details below.
News from NCTM
Briefings from NCTM
One of the EPO Boards of Appeal has ruled on the highly debated issue of human stem cell patentability under the European Patent Convention.
On 7 February 2014, the European Court of Justice (Case 98-13) issued a ruling pertaining to the interpretation of Council Regulation (EC) no. 1383/2003.
Analysis from The Lawyer
Being sent to London on secondment is a prized opportunity for associates in European firms